Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Nautilus Biotechnology Inc., 3 years.
Nautilus Biotechnology Inc.
Director
BioAge Labs Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 3, 2024 | BioAge Labs Inc. | Open-market purchase | +25,306 | $19.90 | $503,589 |
| Oct 2, 2024 | BioAge Labs Inc. | Open-market purchase | +67,096 | $19.73 | $1,323,804 |
| Oct 1, 2024 | BioAge Labs Inc. | Open-market purchase | +126,793 | $19.73 | $2,501,626 |
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +855,972 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +413,100 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +189,609 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +655,294 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +900,000 | $18.00 | $16,200,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.